Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ P10 Inc. (PX) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Asset Management
$10.58
+0.19 (1.83%)Did PX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if P10 is one of their latest high-conviction picks.
Based on our analysis of 14 Wall Street analysts, PX has a bullish consensus with a median price target of $14.00 (ranging from $13.00 to $21.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $10.58, the median forecast implies a 32.3% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Chris Kotowski at Oppenheimer, projecting a 98.5% upside. Conversely, the most conservative target is provided by Benjamin Budish at Barclays, suggesting a 22.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for PX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 14, 2025 | Oppenheimer | Chris Kotowski | Outperform | Maintains | $21.00 |
| May 13, 2025 | JP Morgan | Kenneth Worthington | Overweight | Maintains | $14.50 |
| May 9, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $14.00 |
| Apr 14, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $12.00 |
| Apr 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $13.00 |
| Feb 13, 2025 | Stephens & Co. | John Campbell | Overweight | Maintains | $16.00 |
| Feb 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $15.00 |
| Jan 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $16.00 |
| Jan 7, 2025 | JP Morgan | Kenneth Worthington | Overweight | Upgrade | $15.00 |
| Dec 12, 2024 | Oppenheimer | Chris Kotowski | Outperform | Maintains | $21.00 |
| Dec 9, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $15.00 |
| Nov 12, 2024 | JP Morgan | Kenneth Worthington | Neutral | Maintains | $14.00 |
| Nov 11, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $13.00 |
| Nov 11, 2024 | Stephens & Co. | John Campbell | Overweight | Maintains | $13.00 |
| Nov 8, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Reiterates | $13.00 |
| Oct 22, 2024 | UBS | Adam Beatty | Neutral | Maintains | $12.00 |
| Oct 16, 2024 | Oppenheimer | Chris Kotowski | Outperform | Maintains | $16.00 |
| Oct 10, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $12.00 |
| Oct 7, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $12.00 |
| Aug 21, 2024 | UBS | Adam Beatty | Neutral | Downgrade | $10.50 |
The following stocks are similar to P10 based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
P10 Inc. has a market capitalization of $1.16B with a P/E ratio of 79.9x. The company generates $299.63M in trailing twelve-month revenue with a 4.9% profit margin.
Revenue growth is +2.3% quarter-over-quarter, while maintaining an operating margin of +17.7% and return on equity of +4.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides capital to lower middle-market private equity firms.
The company operates as an alternative asset management firm, generating revenue by offering diversified investment strategies and finance solutions to institutional and high-net-worth investors. Its focus on private equity, venture capital, and impact investing allows it to deliver reliable returns while managing risk effectively.
P10 Inc. has established a strong reputation in the financial market for consistent performance and is instrumental in facilitating economic growth and innovation by investing in businesses during critical development stages.
Financial Services
Asset Management
267
Mr. Luke A. Sarsfield III
United States
2021
Tanger (SKT) delivered FFO and revenue surprises of +3.45% and -0.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
P10, Inc. (PX) will hold its Q3 2025 earnings call on November 6, 2025, at 8:30 AM EST, featuring key executives including the CEO and CFO.
The earnings call provides insights into P10, Inc.'s financial performance and strategic direction, which can influence stock valuation and investor sentiment.
P10, Inc. (NYSE: PX) reported Q3 2025 revenue of $75.9 million, up 2% year over year. Organic fundraising and deployments totaled $915 million, with a 17% increase in fee-paying AUM.
P10, Inc.'s 17% increase in fee-paying AUM and raised annual guidance signal strong growth potential and operational efficiency, positively influencing investor confidence and stock performance.
P10, Inc. (PX) reported quarterly earnings of $0.24 per share, exceeding the Zacks Consensus Estimate of $0.23, but down from $0.26 per share a year prior.
P10, Inc. exceeded earnings expectations, indicating strong performance relative to forecasts. However, a decline from last year's earnings could raise concerns about growth sustainability.
P10 (PX) reported its revenue and EPS for Q3 2025. Investors should compare these figures with Wall Street estimates and year-ago metrics for a comprehensive analysis.
Revenue and EPS figures compared to estimates and prior year indicate growth trends or potential issues, influencing investor sentiment and stock valuation for P10 (PX).
P10 (PX) has a consensus price target indicating a 46.5% upside potential. Upward revisions in earnings estimates may suggest near-term stock gains.
A 46.5% upside target suggests strong growth potential for P10 (PX), while rising earnings estimates may drive investor confidence and stock performance.
P10, Inc. (NYSE: PX) will release its Q3 2025 results on November 6, 2025, before the U.S. markets open.
P10, Inc.'s upcoming earnings release may influence stock performance and investor sentiment, affecting trading decisions based on anticipated financial results and market reactions.
Based on our analysis of 14 Wall Street analysts, P10 Inc. (PX) has a median price target of $14.00. The highest price target is $21.00 and the lowest is $13.00.
According to current analyst ratings, PX has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.58. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict PX stock could reach $14.00 in the next 12 months. This represents a 32.3% increase from the current price of $10.58. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates as an alternative asset management firm, generating revenue by offering diversified investment strategies and finance solutions to institutional and high-net-worth investors. Its focus on private equity, venture capital, and impact investing allows it to deliver reliable returns while managing risk effectively.
The highest price target for PX is $21.00 from Chris Kotowski at Oppenheimer, which represents a 98.5% increase from the current price of $10.58.
The lowest price target for PX is $13.00 from Benjamin Budish at Barclays, which represents a 22.9% increase from the current price of $10.58.
The overall analyst consensus for PX is bullish. Out of 14 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $14.00.
Stock price projections, including those for P10 Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.